Pharma channel feed – Endpoints News

Pharma channel feed

EMA considers serious eye condition a ‘very rare’ side effect of semaglutide

Last week

Pharma imports into the US return to normal after March tariff stockpiling

Last week

Biotech ranks as China’s best shot to surpass US in emerging tech, report finds

Last week

A decade after its ill-fated $40.5B megadeal, Teva pivots from generics to innovation

Last week

Anne Wojcicki and Regeneron set to duke it out in restarted 23andMe auction

Last week

Exclusive: After cutting most staff, Casma eyes path to clinic with its first autophagy-boosting drug

Last week

Ex-HHS workers accuse Trump administration of using flawed data to issue firings

Last week

Struggling biotechs succumb to icy market, as money dries up and clinical bets don’t pay off

Last week

Pharma companies rush in to buy what they hope will rival Keytruda

Last week

FDA commissioner tells Hawley he's 'committed' to doing a mifepristone review

Last week

Q&A: Sandoz CEO Richard Saynor on generic GLP-1s, Trump's industry impact, and Mark Cuban's company

Last week

Enhertu combo has the makings of a new standard in HER2-positive breast cancer

Last week

Bristol Myers bets $1.5B on BioNTech's PD-L1xVEGF from Biotheus

Last week

Vera posts positive Phase 3 rare kidney disease data, but crowded market looms

Last week

FDA approves Moderna’s next-gen Covid vaccine, with limits on most healthy people

3 weeks ago

Enhertu extends life by three months for some stomach cancer patients, study finds

3 weeks ago

Gilead, Merck reveal 'practice-changing' data for Trodelvy-Keytruda combo in aggressive breast cancer

3 weeks ago

Trump administration loses bid to move ahead with HHS firings, reorganization

3 weeks ago

AstraZeneca agrees to pay $51M to settle ‘pay-for-delay’ class action suit

3 weeks ago

HHS says it's pulled Covid shot guidance for healthy kids. The CDC vaccine schedule shows otherwise

3 weeks ago

As a challenging first half nears a close, biopharma uncertainty persists

3 weeks ago

Pfizer's Braftovi combo doubles survival time for some colorectal cancer patients

3 weeks ago

Supreme Court to keep mulling state PBM dispute as US urges justices to decline case

3 weeks ago

Eisai, Merck stave off generic competition to blockbuster cancer drug Lenvima

3 weeks ago

First page Previous page 123 4 5 Next page Last page